Details

Last Funding Type

Series C

Last Funding Money Raised

$65M

Industries

Biotechnology,Health Care,Pharmaceutical

Founded date

Jan 1, 2003

Number Of Employee

251 - 500

Operating Status

Active

Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription therapeutics to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. The company currently is focusing on in-licensing, developing and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area.

Somaxon currently is promoting Silenor®, the first and only nonscheduled prescription medication approved for the treatment of sleep maintenance insomnia. Silenor is now available for prescription in the United States.